Changcun Guo

3.0k total citations
72 papers, 2.3k citations indexed

About

Changcun Guo is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Changcun Guo has authored 72 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 20 papers in Epidemiology and 18 papers in Oncology. Recurrent topics in Changcun Guo's work include Liver Disease Diagnosis and Treatment (15 papers), Drug Transport and Resistance Mechanisms (10 papers) and Inflammatory Bowel Disease (10 papers). Changcun Guo is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Drug Transport and Resistance Mechanisms (10 papers) and Inflammatory Bowel Disease (10 papers). Changcun Guo collaborates with scholars based in China, United States and United Kingdom. Changcun Guo's co-authors include Daiming Fan, Kaichun Wu, Yongquan Shi, Li Sun, Zheyi Han, Yanglin Pan, Taidong Qiao, Yongzhan Nie, Hai Yan and John Beckly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Changcun Guo

70 papers receiving 2.3k citations

Peers

Changcun Guo

ONCOL

IMMUN

GENET

Roland Kappler Germany

Frauke Bataille Germany

Pascal Colosetti France

Karlheinz Holzmann Germany

Koichi Hamada Japan

Hsei–Wei Wang Taiwan

Toby J. Phesse United Kingdom

Esther Bertrán Spain

Ignacio Varela Spain

Michiko Niwa‐Kawakita France

Roland Kappler Germany

Changcun Guo

1.6k ×1.1

399 ×0.7

431 ×1.0

ONCOL

269 ×0.8

IMMUN

323 ×0.9

GENET

Citations per year, relative to Changcun Guo Changcun Guo (= 1×) peers Roland Kappler

Countries citing papers authored by Changcun Guo

Since Specialization

Citations

This map shows the geographic impact of Changcun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changcun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changcun Guo more than expected).

Fields of papers citing papers by Changcun Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changcun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changcun Guo. The network helps show where Changcun Guo may publish in the future.

Co-authorship network of co-authors of Changcun Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Changcun Guo. A scholar is included among the top collaborators of Changcun Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changcun Guo. Changcun Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Yi, et al.. (2025). Burden, trends, and predictions of liver cancer in China, Japan, and South Korea: analysis based on the Global Burden of Disease Study 2021. Hepatology International. 19(2). 441–459. 4 indexed citations

Zhang, Jing, et al.. (2025). Development and validation of a prognostic nomogram for early hepatocellular carcinoma treated with microwave ablation. Frontiers in Oncology. 15. 1486149–1486149. 1 indexed citations

Liu, Yansheng, Changcun Guo, Patrick S.C. Leung, et al.. (2025). The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine. Clinical Reviews in Allergy & Immunology. 68(1). 63–63.

Zhang, Jing, et al.. (2024). Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC. International Journal of Hyperthermia. 41(1). 2318829–2318829. 4 indexed citations

Zhang, Jing, et al.. (2024). Early versus Late Recurrence of Hepatocellular Carcinoma after Microwave Ablation: Patterns, Treatments, and Post-Recurrence Survival. Oncology. 102(9). 785–793.

Tian, Zuhong, Shuhui Liang, Xinmin Zhou, et al.. (2022). Near-infrared-dye labeled tumor vascular-targeted dimer GEBP11 peptide for image-guided surgery in gastric cancer. Frontiers in Oncology. 12. 885036–885036. 2 indexed citations

Guo, Guanya, Bo Li, Xiufang Wang, et al.. (2022). Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion. Hepatology International. 17(1). 237–248. 15 indexed citations

Guo, Changcun, Guanya Guo, Xia Zhou, et al.. (2018). Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 17(6). 1175–1182.e2. 9 indexed citations

Wortham, Matthew, Changcun Guo, Monica Zhang, et al.. (2014). Chromatin Accessibility Mapping Identifies Mediators of Basal Transcription and Retinoid-Induced Repression of OTX2 in Medulloblastoma. PLoS ONE. 9(9). e107156–e107156. 7 indexed citations

10.

Sun, Li, Lili Liu, Xiangqiang Liu, et al.. (2014). Gastric cancer cell adhesion to laminin enhances acquired chemotherapeutic drug resistance mediated by MGr1-Ag/37LRP. Oncology Reports. 32(1). 105–114. 15 indexed citations

11.

Kang, Jianqin, Guohong Zhao, Tao Lin, et al.. (2013). A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells. Cancer Letters. 339(2). 247–259. 57 indexed citations

12.

Yao, Liping, Fei Liu, Li Sun, et al.. (2010). Upregulation of PPARγ in Tissue with Gastric Carcinoma. Hybridoma. 29(4). 341–343. 14 indexed citations

13.

Ding, Rui, Shuang Han, Yuanyuan Lu, et al.. (2010). Overexpressed Id-1 is associated with patient prognosis and HBx expression in hepatitis B virus-related hepatocellular carcinoma. Cancer Biology & Therapy. 10(3). 299–307. 27 indexed citations

14.

Li, Zhikui, Changcun Guo, Yongzhan Nie, et al.. (2010). Screening and Identification of Recombinant Anti-Idiotype Antibodies against Gastric Cancer and Colon Cancer Monoclonal Antibodies by a Phage-Displayed Single-Chain Variable Fragment Library. SLAS DISCOVERY. 15(3). 308–313. 5 indexed citations

15.

Liang, Jie, Changcun Guo, Guanhong Luo, et al.. (2008). Inhibition of PI3K/Akt partially leads to the inhibition of PrP^C‐induced drug resistance in gastric cancer cells. FEBS Journal. 276(3). 685–694. 42 indexed citations

16.

Guo, Changcun, et al.. (2008). The Expression of Runx3 in Ulcerous Colitis. Xiandai shengwu yixue jinzhan. 2 indexed citations

17.

Han, Zheyi, Kaichun Wu, Chunying Li, et al.. (2008). Akt1/protein Kinase Bα is Involved in Gastric Cancer Progression and Cell Proliferation. Digestive Diseases and Sciences. 53(7). 1801–1810. 30 indexed citations

18.

Liu, Lili, Xiaoxuan Ning, Yi Liu, et al.. (2007). Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells. Molecular and Cellular Biochemistry. 303(1-2). 151–160. 23 indexed citations

19.

Liang, Shuhui, Tao Lin, Jie Ding, et al.. (2006). Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer. Journal of Molecular Medicine. 84(9). 764–773. 53 indexed citations

20.

Guo, Changcun. (2003). Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuatedsalmonella typhimuriumas carrier. World Journal of Gastroenterology. 9(6). 1191–1191. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact